Ledger.Open graph →
SEC Form D · Amendment · filed January 12, 2021

Elucida Oncology, Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Kai Ma · Monmouth Junction, NJExecMichael Smith · Monmouth Junction, NJDirectorJosh Froelich · Houston, TXExecRobert Ruffolo · Monmouth Junction, NJDirectorDane F. Lund · New York, NYDirectorJakub Rehor · Reno, NVExecJohn M. Courtright · Elmhurst, ILDirectorGeno Germano · Monmouth Junction, NJExec · DirectorMelissa Weiler · New York, NYExecDavid Anthony · Broomfield, CODirectorTim Boris · Monmouth Junction, NJDirectorRobert Essner · Monmouth Junction, NJExec · DirectorMichael Wolfgramm · Orem, UTExec · DirectorJonathan Lamm · New York, NYExecJan F. Van Eck · New York, NYDirectorDion F. Chu · New York, NYExec · DirectorSpencer Patterson · Orem, UTExec · DirectorTeresa Ressel · Monmouth Junction, NJDirectorRalph Yarro · Orem, UTDirectorVictor D. Woolridge · New York, NYExecUlrich Wiesner · Monmouth Junction, NJDirectorGregory Adams · Monmouth Junction, NJExecJonathan R. Simon · New York, NYDirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorKasper Bihlet · Houston, TXExecMichael F. Peng · New York, NYDirectorEliel Bayever · Monmouth Junction, NJExecAyman M. Shahin · Dubai, C0DirectorKara Forney · Albuquerque, NMDirectorHelene Servillon · Dover, DEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗